Home
Home

alogliptin

Furiex Rises on FDA Approval of Takeda Diabetes Medicine

Furiex Rises on FDA Approval of Takeda Diabetes Medicine
Bloomberg

FDA announces approval of three new drugs to treat Type 2 diabetes

FDA announces approval of three new drugs to treat Type 2 diabetes
examiner.com

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval

Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg

Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA

Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
NASDAQ

FDA Delays Takeda's Replacement for Actos

FDA Delays Takeda's Replacement for Actos
Injury Board

Takeda submits new drug application in the U.S. for Type 2 Diabetes Continue reading on Examiner.com Takeda submits new drug application in the U.S. for Type 2 Diabetes

Takeda submits new drug application in the U.S. for Type 2 Diabetes Continue reading on Examiner.com Takeda submits new drug application in the U.S. for Type 2 Diabetes
Wall Street Journal

Takeda heads back to FDA with diabetes blockbuster hopeful

Takeda heads back to FDA with diabetes blockbuster hopeful
Fierce Biotech

News

Takeda to begin cardiovascular outcomes trial for alogliptin to treat type 2 diabetes
Pharmabiz
»

News

Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes
PR NewsWire
»

News

PPD shares fall on diabetes drug setback
Yahoo/AP
»